Sumoylation-dependent Control of Homotypic and Heterotypic Synergy by the Krüppel-type Zinc Finger Protein ZBP-89*

The Krüppel-like transcription factor ZBP-89 is a sequence-specific regulator that plays key roles in cellular growth and differentiation especially in endodermal and germ cell lineages. ZBP-89 shares with other members of the Sp-like family an overlapping sequence specificity for GC-rich sequences in the regulatory regions of multiple genes. Defining the mechanisms that govern the intrinsic function of ZBP-89 as well as its competitive and non-competitive functional interactions with other regulators is central to understand how ZBP-89 exerts its biological functions. We now describe that post-translational modification of ZBP-89 by multiple small ubiquitin-like modifier (SUMO) isoforms occurs at two conserved synergy control motifs flanking the DNA binding domain. Functionally sumoylation did not directly alter the ability of ZBP-89 to compete with other Sp-like factors from individual sites. At promoters bearing multiple response elements, however, this modification inhibited the functional cooperation between ZBP-89 and Sp1. Analysis of the properties of ZBP-89 in cellular contexts devoid of competing factors indicated that although on its own it behaves as a modest activator it potently synergizes with heterologous activators such as the glucocorticoid receptor. Notably we found that when conjugated to ZBP-89, SUMO exerts a strong inhibitory effect on such synergistic interactions through a critical conserved functional surface. By regulating higher order functional interactions, sumoylation provides a reversible post-translational mechanism to control the activity of ZBP-89.

[1]  J. Merchant,et al.  The human ZBP-89 homolog, located at Chromosome 3q21, represses gastrin gene expression , 1998, Mammalian Genome.

[2]  Z. Zehner,et al.  The zinc finger repressor, ZBP‐89, recruits histone deacetylase 1 to repress vimentin gene expression , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[3]  Stefani N. Thomas,et al.  Doxorubicin Down-regulates Krüppel-associated Box Domain-associated Protein 1 Sumoylation That Relieves Its Transcription Repression on p21WAF1/CIP1 in Breast Cancer MCF-7 Cells* , 2007, Journal of Biological Chemistry.

[4]  Ming-Jing Hwang,et al.  Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. , 2006, Molecular cell.

[5]  E. Lam,et al.  Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone , 2006, Proceedings of the National Academy of Sciences.

[6]  J. Merchant,et al.  Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia , 2006, Mammalian Genome.

[7]  C. Shelley,et al.  The transcription factor ZBP-89 controls generation of the hematopoietic lineage in zebrafish and mouse embryonic stem cells , 2006, Development.

[8]  Alison M. Urvalek,et al.  Sumoylation Delimits KLF8 Transcriptional Activity Associated with the Cell Cycle Regulation* , 2006, Journal of Biological Chemistry.

[9]  E. Yeh,et al.  Characterization of a Family of Nucleolar SUMO-specific Proteases with Preference for SUMO-2 or SUMO-3* , 2006, Journal of Biological Chemistry.

[10]  E. Kieff,et al.  NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Brattain,et al.  Sumoylation Inhibits Cleavage of Sp1 N-terminal Negative Regulatory Domain and Inhibits Sp1-dependent Transcription* , 2006, Journal of Biological Chemistry.

[12]  J. Merchant,et al.  An isoform of ZBP-89 predisposes the colon to colitis , 2006, Nucleic acids research.

[13]  David Owerbach,et al.  A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. , 2005, Biochemical and biophysical research communications.

[14]  H. Cohen,et al.  Glucocorticoids Regulate Transcription of the Gene for Phosphoenolpyruvate Carboxykinase in the Liver via an Extended Glucocorticoid Regulatory Unit* , 2005, Journal of Biological Chemistry.

[15]  David Reverter,et al.  Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex , 2005, Nature.

[16]  J. Iñiguez-Lluhí,et al.  A Small Conserved Surface in SUMO Is the Critical Structural Determinant of Its Transcriptional Inhibitory Properties , 2005, Molecular and Cellular Biology.

[17]  R. Hay,et al.  SUMO: a history of modification. , 2005, Molecular cell.

[18]  G. Goubin,et al.  A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo , 2005, Molecular and Cellular Biochemistry.

[19]  T. A. Wilkinson,et al.  Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Shirakawa,et al.  Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. , 2004, Molecular endocrinology.

[21]  M. Atchison,et al.  Regulation of Murine Cytochrome c Oxidase Vb Gene Expression during Myogenesis , 2004, Journal of Biological Chemistry.

[22]  D. Granner,et al.  The Synergistic Effect of Dexamethasone and All-trans-retinoic Acid on Hepatic Phosphoenolpyruvate Carboxykinase Gene Expression Involves the Coactivator p300* , 2004, Journal of Biological Chemistry.

[23]  K. Bohren,et al.  A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.

[24]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[25]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[26]  J. Merchant,et al.  Transcription factor ZBP-89 is required for STAT1 constitutive expression. , 2003, Nucleic acids research.

[27]  J. Iñiguez-Lluhí,et al.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Nakao,et al.  Modification of GATA‐2 Transcriptional Activity in Endothelial Cells by the SUMO E3 Ligase PIASy , 2003, Circulation research.

[29]  Z. Zehner,et al.  ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. , 2003, Nucleic acids research.

[30]  C. Shelley,et al.  The zinc finger transcription factor ZBP-89 is a repressor of the human beta 2-integrin CD11b gene. , 2003, Blood.

[31]  Y. Mishina,et al.  Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis , 2003, Nature Genetics.

[32]  J. Iñiguez-Lluhí,et al.  A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.

[33]  F. Melchior,et al.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1 , 2002, The EMBO journal.

[34]  L. Zon,et al.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.

[35]  H. Su,et al.  Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. , 2002, Gene.

[36]  A. Dejean,et al.  The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.

[37]  L. Bruhn,et al.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.

[38]  J. Merchant,et al.  ZBP-89 Promotes Growth Arrest through Stabilization of p53 , 2001, Molecular and Cellular Biology.

[39]  R. Perlmutter,et al.  Identification and Characterization of a Transcriptional Regulator for the lck Proximal Promoter* , 2001, The Journal of Biological Chemistry.

[40]  J. Palvimo,et al.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Hirofumi Tanaka,et al.  A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. , 2000, European journal of biochemistry.

[42]  J. Merchant,et al.  Transcription Factor ZBP-89 Cooperates with Histone Acetyltransferase p300 during Butyrate Activation of p21 waf1 Transcription in Human Cells* , 2000, The Journal of Biological Chemistry.

[43]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[44]  E. Yeh,et al.  Ubiquitin-like proteins: new wines in new bottles. , 2000, Gene.

[45]  Z. Zehner,et al.  The Zinc Finger Repressor, ZBP-89, Binds to the Silencer Element of the Human Vimentin Gene and Complexes with the Transcriptional Activator, Sp1* , 2000, The Journal of Biological Chemistry.

[46]  M. Waterman,et al.  Three zinc finger nuclear proteins, Sp1, Sp3, and a ZBP-89 homologue, bind to the cyclic adenosine monophosphate-responsive sequence of the bovine adrenodoxin gene and regulate transcription. , 2000, Biochemistry.

[47]  H. Saitoh,et al.  Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.

[48]  A. Henney,et al.  Human stromelysin gene promoter activity is modulated by transcription factor ZBP‐89 , 1999, FEBS letters.

[49]  G. Mize,et al.  Transcription Factor ZBP-89 Regulates the Activity of the Ornithine Decarboxylase Promoter* , 1998, The Journal of Biological Chemistry.

[50]  G. Barbieri,et al.  Negative Regulation of β Enolase Gene Transcription in Embryonic Muscle Is Dependent upon a Zinc Finger Factor That Binds to the G-rich Box within the Muscle-specific Enhancer* , 1998, The Journal of Biological Chemistry.

[51]  B. de Crombrugghe,et al.  Cloning and Characterization of a Transcription Factor That Binds to the Proximal Promoters of the Two Mouse Type I Collagen Genes* , 1997, The Journal of Biological Chemistry.

[52]  K. Yamamoto,et al.  Three Amino Acid Substitutions Selectively Disrupt the Activation but Not the Repression Function of the Glucocorticoid Receptor N Terminus* , 1997, The Journal of Biological Chemistry.

[53]  R. Bassel-Duby,et al.  ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter , 1996, Molecular and cellular biology.

[54]  C. Kaltschmidt,et al.  Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s). , 1991, Molecular endocrinology.

[55]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[56]  G. Schütz,et al.  Synergistic action of the glucocorticoid receptor with transcription factors. , 1988, The EMBO journal.

[57]  B. Gloss,et al.  Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene , 1987, Cell.